National Cancer Institute (NCI)

Search Our Work by NIH Institute/Center

Partnerships with this Institute

Key Initiatives

The Biomarkers Consortium

This groundbreaking initiative expands the science of personalized medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.

Lectures & Awards

Pew Latin American Fellow Awards

The Pew Charitable Trusts worked through the Foundation for NIH to award grants totaling $225,000 to three postdoctoral fellows at NIH. The Pew Latin American Fellows Program in Biomedical Sciences aims to help develop a generation of highly trained researchers who can stimulate and contribute to the growth of important biomedical research and to foster collaboration between scientists in Latin America and the United States.

Key Initiatives

I-SPY 2: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis

The I-SPY 2 trial employs a groundbreaking clinical trial model that uses genetic or biological markers (“biomarkers”) from individual patients’ tumors to screen promising new treatments, identifying which treatments are most effective in specific types of patients.

Past Programs

Understanding Targeted Cancer Therapies Tutorials

This project, made possible by $650,000 in private-sector contributions to the Foundation for NIH, was overseen by the National Cancer Institute.

Program

Endotoxin Research Project

The use of bacterial endotoxin in clinical research is essential to the study of the effects of inflammation on the body and as a potent stimulus to enhance immune responses in clinical trials of anti-cancer immunotherapy.

Program

Imaging Database Resources Initiative (IDRI)

Imaging software analysis of digital data collected by X-ray CT, MRI, CT and PET is increasingly central to the diagnosis and treatment of cancer. New software methods for interpreting and managing this information must be evaluated in a more standardized manner to ensure their optimum performance.

Program

Biotechnology Resource for Innovation and Development in Genomedicine (BRIDGE)

BRIDGE is a public-private consortium with the goal of developing gene-specific anticancer therapies to advance cancer treatment. The project applies new systems biology strategies to identify genes that are aberrant in cancer cells.

Scholarships & Fellowships

Sallie Rosen Kaplan Fellowship

The Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research at the National Cancer Institute is made possible by a generous bequest from Sallie Rosen Kaplan.

Education & Training

Targeted Cancer Therapies Tutorials

Understanding Targeted Therapies for Cancer is an animated, educational tutorial series developed by the National Cancer Institute for health professionals. The tutorials, available online or in DVD format, provide practitioners with an overview of targeted cancer therapies, the latest FDA-approved targeted therapy drugs, and active clinical trials involving these treatments.

Program

Overcoming Barriers to Early Phase Clinical Trials

This program, through the National Cancer Institute (NCI), provided approximately $6 million to cancer centers to design and implement new approaches to increase patient participation in early-stage clinical trials—particularly in minority and underserved populations.

Past Programs

Avon-NCI Progress for Patients (PFP)

The Avon-NCI Progress for Patients Awards Program, completed in 2009, made a significant impact on breast cancer research, accelerating the movement of pre-clinical discoveries to application in patients, and fostering collaborative efforts that optimized resources and efficiencies.

Program

Human Papilloma Virus Clinical Trial

Human papilloma virus (HPV) is the primary cause of cervical cancer. With more than $6 million in support from the Foundation for NIH, investigators have expanded the scope of an existing National Cancer Institute (NCI) Phase III clinical trial examining a vaccine intended to prevent cervical and other cancers caused by this virus. The expansion makes possible validation, regulatory support and quality-assurance monitoring of the vaccine. The goal is to ensure that the resulting discoveries can be quickly translated into therapies that will prevent the spread of HPV.

Donate button

What is the National Institutes of Health?

The National Institutes of Health (NIH) is a part of the U.S. Department of Health and Human Services. Comprised of 27 institutes and centers, the NIH is the primary federal agency for conducting and supporting medical research.

NIH scientists investigate ways of treating, preventing, and even curing common and rare diseases. Learn more by visiting NIH's Web site.

Latest Press Releases
2012 Heart Truth® Community Action Program Grant Recipients
The FNIH Biomarkers Consortium Announces Availability of Alzheimer’s Disease Biomarker Data
FCC Chairman Julius Genachowski to Deliver Address at 2011 mHealth Summit
U.S. Surgeon General Regina Benjamin to Deliver Keynote Address at 2011 mHealth Summit
HHS Secretary Kathleen Sebelius to Deliver Opening Keynote at 2011 mHealth Summit
More »

Upcoming Events
More »